136 results
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
to intensive guidance on an efficient development program beginning as early as Phase 1, and FDA organizational commitment to expedited development
424B5
CYCC
Cyclacel Pharmaceuticals Inc
26 Dec 23
Prospectus supplement for primary offering
9:28am
purchaser or purchasers and the terms of their commitment, if any;
whether stockholders are entitled to oversubscription rights, if any;
any applicable … basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis.
The distribution
424B5
xajn9ad
30 Mar 22
Prospectus supplement for primary offering
5:28pm
424B5
75oz zkfrv2
12 Aug 21
Prospectus supplement for primary offering
5:07pm
424B5
j4zu1ay zrybm
12 Mar 21
Prospectus supplement for primary offering
9:41pm
424B5
s53 30yuxw
11 Mar 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
wmj9ib
22 Dec 20
Cyclacel Pharmaceuticals ANNOUNCES At-the-market $7 MILLION strategic INVESTMENT BY FUNDAMENTAL INVESTOR ACORN BIOVENTURES
4:05pm
424B5
54184
22 Dec 20
Prospectus supplement for primary offering
8:06am
424B5
ox2mo 5sqdn
4 Oct 18
Prospectus supplement for primary offering
5:02pm
8-K
EX-5.1
9rd1l25i nkfmlxtcl
21 Jul 17
Cyclacel Announces Closing of $15.2 Million Underwritten Public Offering
12:00am
424B2
x0t2pr ol
10 Jun 16
Prospectus for primary offering
12:00am